Philips 2011 Annual Report Download - page 16

3 Our strategy in action 3 - 3
16 Annual Report 2011
As we began this journey, we also set a goal for ourselves:
to become one of the CT and MR market leaders in China.
Today, our CT and MR offerings serve a wide range of
needs in environments from rural community hospitals to
the country’s leading teaching hospitals. The cooperative
effort within our China Team – encompassing our MR and
CT businesses, sales and service – and targeted
collaborations with customers got us to our goal of
becoming one of the imaging technology leaders in China.
“The Center for Biomedical Imaging Research at Tsinghua
University chose Philips 3T Achieva TX as its main
research scanner,” says Chun Yuan, Ph.D, the Center’s
Director. “With the help of many different branches
within Philips, especially Philips China, and through
scientific collaboration, our researchers were able to start
active imaging research in several focus areas in
cardiovascular, tumor and neurological imaging.”
The success of our CT and MR business’s China journey
is reflected in its growth performance, with sales tripling
in the period 2007-2010. This momentum continued in
2011, with a double-digit annual growth rate.
We are succeeding in China because our focus extends
beyond sales. We are committed to enhancing patients’
lives through our clinical expertise and working with our
customers to improve the ability to deliver care. With our
complete imaging portfolio, today we are even better
positioned to help China meet its growing clinical care
needs. The next phase of the journey? China plans to make
significant investments in county-level hospitals and in
digitization to improve healthcare informatics and clinical
decision support. As a global healthcare leader and
working partner with China, Philips will be there every
step of the way.
Global demographic and
environmental trends, such as aging
populations and the rise of chronic
diseases like congestive heart failure,
breast and other cancers, respiratory
and other coronary artery diseases,
will require a fundamental shift in the
way healthcare is provided.
In the hospital domain, we are driven
to improve the way both patients
and professionals experience
healthcare, to improve clinical
outcomes, and to enable the delivery
of quality healthcare at lower cost.
By focusing on the range of medical
issues associated with oncology,
cardiology and women’s health, we
can deliver better, more
differentiated solutions that are more
clinically relevant.